Logo Image

Video Shorts

Ignacio Blanco, MD, PhD, discusses the clinical significance of the EU approval of mirdametinib for NF1-associated neurofibromas.
0:43
EU Approval of Mirdametinib for NF1-Associated PNs
9 months ago
by
Ignacio Blanco, MD, PhD
Breelyn Wilky, MD, discusses the prevalence of KIT mutations and development of treatment resistance in gastrointestinal stromal tumors.
0:38
KIT Mutations and Treatment Resistance in GIST: What You Need to Know
9 months ago
by
Breelyn A. Wilky, MD
Jorge Cortes, MD
2:05
Positive Research Findings Have Shifted Historical Treatment Standards in Hematologic Malignancies
9 months ago
by
Jorge Cortes, MD
Professor Timothy Elliott
2:46
Advances in Therapeutic Cancer Vaccines May Give Way to Cancer Prevention Strategies
9 months ago
by
Professor Timothy Elliott
Shubham Pant, MD, MBBS
1:20
The Future of Vaccine Therapy for Targeting Micrometastatic Disease in Pancreatic Cancer
9 months ago
by
Shubham Pant, MD, MBBS
David A. Braun, MD, PhD
0:39
Immune Checkpoint Expression Differences Shown Between Chromophobe RCC and Clear Cell RCC
9 months ago
by
David A. Braun, MD, PhD